In VitroandIn VivoStudy of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide
- 1 January 2003
- journal article
- research article
- Published by Informa UK Limited in Journal of Drug Targeting
- Vol. 11 (1), 19-24
- https://doi.org/10.1080/1061186031000086108
Abstract
Solid Lipid Nanoparticles (SLN) are already under investigation as a pharmaceutical tool able to change the pharmacokinetic and biodistribution of carried molecules. SLN are able to target drugs to lymph after duodenal administration and to overcome the Blood Brain Barrier (BBB). In this study, superparamagnetic SLN have been prepared, have colloidal size, in vitro analysis showed relaxometric properties similar to Endorem®. In vivo Magnetic Resonance Imaging (MRI) of the central nervous system (CNS) with both SLN and Endorem® showed that superparamagnetic SLN have slower blood clearance than Endorem®. MRI data are consistent with CNS uptake of SLN lasting up to the end of the experiment (135 min). These findings confirm the ability of SLN to overcome the BBB; SLN might be used as a CNS MRI contrast agent.Keywords
This publication has 16 references indexed in Scilit:
- Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (sln) after duodenal administration to rats. Part II—Tissue distributionPharmacological Research, 2001
- Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I—A pharmacokinetic studyPharmacological Research, 2000
- Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacological Research, 2000
- Biodistribution of Stealth and Non-stealth Solid Lipid Nanospheres after Intravenous Administration to RatsJournal of Pharmacy and Pharmacology, 2000
- Determination of Ca, Mg, Fe, Cu, and Zn in blood fractions and whole blood of humans by ICP-OES.Analytical and Bioanalytical Chemistry, 2000
- Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relation with magnetic resonance imaging.Biology of the Cell, 1999
- NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexesEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to RatsPharmaceutical Research, 1998
- Superparamagnetic iron oxides as positive MR contrast agents: In vitro and in vivo evidenceMagnetic Resonance Imaging, 1993
- Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.Radiology, 1987